This webinar explores how to generate meaningful, actionable data using PCR platforms and align assay design with regulatory, operational, and scientific goals across early- and late-phase trials in gene therapy, cell therapy, and oncology.
Join experts from Precision for Medicine, as well as guest speakers from Avidity Biosciences and Indaptus Therapeutics, as they explore how PCR-based molecular monitoring drives smarter, faster, and more efficient personalized clinical trials.
Key Takeaways:
- Optimizing PCR in Clinical Trials: Discover how PCR enables early detection, biological endpoints, patient stratification, and real-time monitoring in oncology, gene and cell therapy trials
- Accelerated Assay Development: Examine factors that enable faster assay development and validation, including reagent availability, platform readiness, and timelines critical to dose escalation studies
- Assay Strategy & Selection: Learn from Precision’s experts about designing, validating, and implementing various qPCR and ddPCR assays to achieve clinical and regulatory milestones while balancing sensitivity and cost
- Applications Across Therapeutic Areas: Understand the latest in PCR technology to measure gene expression, vector copy number, biodistribution, shedding, persistence, replication-competent lentivirus (RCL), and pharmacokinetics (PK) and pharmacodynamic (PD) endpoints
- Case Studies in Action: Hear first-hand from leading biotechnology companies on case studies using scientific innovation to advance novel therapeutic milestones in clinical studies
Watch now to unlock the full potential of PCR in your clinical development strategy.
Offered Free by: Precision for Medicine
See All Resources from: Precision for Medicine
